Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-01
2011-11-29
Seaman, D M (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S153000
Reexamination Certificate
active
08067438
ABSTRACT:
Compounds of formula (I):wherein B, X, R3, L0, L1, L2, R2, R1and RCare defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
REFERENCES:
patent: 4691007 (1987-09-01), Dutta et al.
patent: 5164402 (1992-11-01), Brighty
patent: 5633388 (1997-05-01), Diana et al.
patent: 5962638 (1999-10-01), Naumann et al.
patent: 5994311 (1999-11-01), Eichner et al.
patent: 6143715 (2000-11-01), Llinas-Brunet et al.
patent: 6159938 (2000-12-01), Gyorkos et al.
patent: 6187905 (2001-02-01), Hurst et al.
patent: 6277830 (2001-08-01), Ganguly et al.
patent: 6323180 (2001-11-01), Llinas-Brunet et al.
patent: 6329379 (2001-12-01), Llinas-Brunet et al.
patent: 6329417 (2001-12-01), Llinas-Brunet et al.
patent: 6337394 (2002-01-01), Karlsson et al.
patent: 6410531 (2002-06-01), Llinas-Brunet et al.
patent: 6420380 (2002-07-01), Llinas-Brunet et al.
patent: 6455571 (2002-09-01), Maring et al.
patent: 6534523 (2003-03-01), Bailey et al.
patent: 6608027 (2003-08-01), Tsantrizos et al.
patent: 6642204 (2003-11-01), Llinas-Brunet et al.
patent: 6767991 (2004-07-01), Llinas-Brunet et al.
patent: 6846806 (2005-01-01), Priestley
patent: 6869964 (2005-03-01), Campbell et al.
patent: 6872805 (2005-03-01), Campbell et al.
patent: 6878722 (2005-04-01), Campbell et al.
patent: 6908901 (2005-06-01), Bailey et al.
patent: 6919423 (2005-07-01), Llinas-Brunet
patent: 6939854 (2005-09-01), Priestley
patent: 6995174 (2006-02-01), Wang et al.
patent: 7041698 (2006-05-01), Ripka et al.
patent: 7091184 (2006-08-01), Llinas-Brunet et al.
patent: 7132504 (2006-11-01), Scola et al.
patent: RE40525 (2008-09-01), Llinas-Brunet et al.
patent: 7585845 (2009-09-01), Llinas-Brunet et al.
patent: 7705146 (2010-04-01), Bailey et al.
patent: 7939667 (2011-05-01), Llinas-Brunet et al.
patent: 2002/0111313 (2002-08-01), Campbell et al.
patent: 2003/0186895 (2003-10-01), Llinas-Brunet et al.
patent: 2003/0191067 (2003-10-01), Llinas-Brunet et al.
patent: 2004/0033959 (2004-02-01), Chen et al.
patent: 2004/0072761 (2004-04-01), Campbell et al.
patent: 2004/0077551 (2004-04-01), Campbell et al.
patent: 2004/0106559 (2004-06-01), Wang et al.
patent: 2004/0224900 (2004-11-01), Bailey et al.
patent: 2005/0020503 (2005-01-01), Llinas-Brunet et al.
patent: 2005/0187165 (2005-08-01), Scola et al.
patent: 2006/0019905 (2006-01-01), Bailey et al.
patent: 2006/0046965 (2006-03-01), Bailey et al.
patent: 2006/0258868 (2006-11-01), Bailey et al.
patent: 2445938 (2000-02-01), None
patent: 2429359 (2002-08-01), None
patent: 2474156 (2003-08-01), None
patent: 2486308 (2003-12-01), None
patent: 19600034 (1997-07-01), None
patent: 2337262 (1999-11-01), None
patent: 1135478 (1989-05-01), None
patent: 05155827 (1993-06-01), None
patent: 10298151 (1998-11-01), None
patent: 11127861 (1999-05-01), None
patent: 11137252 (1999-05-01), None
patent: 11292840 (1999-10-01), None
patent: 01103993 (2001-04-01), None
patent: 9533763 (1995-12-01), None
patent: 9706804 (1997-02-01), None
patent: 9743310 (1997-11-01), None
patent: 9817679 (1998-04-01), None
patent: 9822496 (1998-05-01), None
patent: 9846597 (1998-10-01), None
patent: 9846630 (1998-10-01), None
patent: 9853814 (1998-12-01), None
patent: 9907733 (1999-02-01), None
patent: 9907734 (1999-02-01), None
patent: 9938888 (1999-08-01), None
patent: 9950230 (1999-10-01), None
patent: 9964442 (1999-12-01), None
patent: 0009543 (2000-02-01), None
patent: 0009558 (2000-02-01), None
patent: 0020400 (2000-04-01), None
patent: 0031129 (2000-06-01), None
patent: 0059929 (2000-10-01), None
patent: 0102424 (2001-01-01), None
patent: 0107407 (2001-02-01), None
patent: 0116357 (2001-03-01), None
patent: 0132691 (2001-05-01), None
patent: 0140262 (2001-06-01), None
patent: 0158929 (2001-08-01), None
patent: 0164678 (2001-09-01), None
patent: 0174768 (2001-10-01), None
patent: 0177113 (2001-10-01), None
patent: 0181325 (2001-11-01), None
patent: 0208187 (2002-01-01), None
patent: 0208198 (2002-01-01), None
patent: 0208244 (2002-01-01), None
patent: 0208251 (2002-01-01), None
patent: 0208256 (2002-01-01), None
patent: 0218369 (2002-03-01), None
patent: 02060926 (2002-08-01), None
patent: 02079234 (2002-10-01), None
patent: 03053349 (2003-07-01), None
patent: 03064416 (2003-08-01), None
patent: 03064455 (2003-08-01), None
patent: 03064456 (2003-08-01), None
patent: 03099274 (2003-12-01), None
patent: 03099316 (2003-12-01), None
patent: 2004032827 (2004-04-01), None
patent: 2004043339 (2004-05-01), None
patent: 2004101602 (2004-11-01), None
patent: 2004101605 (2004-11-01), None
patent: 2004103996 (2004-12-01), None
patent: 2005028501 (2005-03-01), None
patent: 2005046712 (2005-05-01), None
patent: 2006000085 (2006-01-01), None
patent: 2006004455 (2006-01-01), None
Smith, et al; Synthesis and Pharmacological Activity of Angiotensin Converting Enzyme Inhibitors: N-(Mercaptoacyl)-4-substituted-(S)-prolines; Journal of Medicinal Chemistry; 1988; vol. 31; pp. 875-885.
Perrone; 2-(Aryloxy)ethylamine Derivatives: Ring Opened Congeners of Long Chain 1-Arylpiperazine with High 5-HT1A Receptor Affinity and Selectivity Versus D2 and a1 Receptors; Medicinal Chemistry Research; 1999; vol. 9; No. 5; pp. 340-353.
Gaucher, et al; Palladium (0) Catalyzed Tandem Alkylation and SN′ Cyclization of 1,4-Dichlorobut -2-ene by the N-(Diphenylmethylene) acetonitrile. A Stereoselective Synthesis of 1-Aminocyclo-propanecarboxylic Acids; Tetrahedron Letters; 1995; vol. 36; No. 17; pp. 2979-2982.
Fliche, et al; Enantioselective synthesis of (1R,2S) and (1S,2S) dehydrocoronamic acids; Synthetic Communications; 1994; vol. 24; No. 20; pp. 2873-2876.
Chen, et al; Chirally selective hydrolysis of D, L amino acid esters by alkaline protease; J. Chem, Soc. Chem. Commun.; 1986; vol. 20; pp. 1514-1516.
Llinas-Brunet; et al; Peptide-based inhibitors of the hepatitis C virus serine protease; Bioorganic & Medicinal Chemistry Letters; 1998; vol. 8; pp. 1713-1718.
Gershonov, et al; 1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs; Journal of Medicinal Chemistry; 1996; vol. 39; No. 24; pp. 4833-4843.
Chen, et al; Kinetic resolution of esters of amino acids in t-butanol containing 5% water catalyzed by a stable industrial alkaline protease; Chirality; 1994; vol. 6; pp. 572-576.
Ogawa, et al; 2,3-Methanophenylalanine and.Alpha., .Beta.-Dehydrophenylalanine Derivatives as Chymotrypsin Inhibitor; PEPT. Chem. (1990); vol. 27; pp. 379-382.
Llinas-Brunet, et al; Studies on the C-terminal of Hexapeptide Inhibitors of the Hepatitis C Virus Serine Protease; Bioorganic & Medicinal Chemistry Letters; 1998; vol. 8; pp. 2719-2724, 1998.
Huang, et al; Olefin Methathesis-Active Ruthenium Complexes Bearing a Nucleophilic Carbene Ligand; Journal of American Chemical Society; 1999; vol. 121; pp. 2674-2678.
Kingsbury, et al; A Recycable Ru-Based Methathesis Catalyst; Journal of American Chemical Society; 1999; vol. 121; pp. 791-799.
Krchnak, et al; Polymer-Supported Mitsunobu Ether Formation and its Use in Combinatorial Chemistry; Tetrahedron Letters; 1995; vol. 36; No. 35; pp. 6193-6196.
Lohmann, et al; Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line; Science; Jul. 2, 1999; vol. 285; pp. 110-113.
Miller, et al; Application of Ring-Closing Methathesis to the Synthesis of Rigidified Amino Acids and Peptides; Journal of American Chemical Society; 1996; vol. 118; pp. 9606-9614.
Nizi, et al; Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease; Bioorganic & Medicinal Chemistry Letters 14: (2004); pp. 2151-2154.
Rano, et al; Solid Phase Synthesis of Aryl Ethers via the Mitsunobu Reaction; Tetrahedron Letters; 1995; vol. 36; No. 22; pp. 3789-3792.
Still, et al; Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution; Journal of Organic Chemistry; 1978; vol. 43; No. 14.
Llinas-Brunet, et al; Peptide-Based Inhibitors of the Hepatitis C Virus Serine Protease; Bioorganic & Medicinal Chemistry Letters; 1998; vol. 8; No. 13; pp. 1713-1718.
Ingallinella, et al; Pot
Bailey Murray Douglas
Bhardwaj Punit R.
Bordeleau Josee
Forgione Pasquale
Ghiro Elise
Boehringer Ingelheim International GmbH
Datlow Philip I.
Morris Michael P.
Seaman D M
LandOfFree
Hepatitis C inhibitor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C inhibitor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C inhibitor compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4256193